FindTrial
Sign In

Observation of surgical related Cosmesis and Cosmesis related outcome reported by patients after patient’s breast conservation surgery and reconstruction

Surgical Cosmesis And patient reported outcome measures in patients who have undergone tRansposition flap reconstruction after BCS (SCAR) - SCAR Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/066667
Enrollment
200
Registered
2024-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Nil: NIl Control Intervention1: Nil: Nil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients who have undergone a breast conservative surgery (from Jun 2014 to June 2023) with a Transposition Flap 2.All patients willing for the study

Exclusion criteria

Exclusion criteria: 1.All patients undergoing procedures other than Transposition Flap. 2.All metastatic patients. 3.Patients not willing to give consent. 4.Pregnant women

Design outcomes

Primary

MeasureTime frame
Patient reported outcome measure obtained by the BREAST-Q BCS module. Timepoint: the patients will be administered the BREAST-Q BCS module at Baseline visit—

Secondary

MeasureTime frame
1.Clinical outcome parameters such as margin positive rate, local recurrence and disease-free survival. 2.Subjective cosmetic assessment by Modified Harvard Scale5 3.Objective cosmetic assessment by BCCT.Core software Timepoint: at baseline visit—

Countries

India

Contacts

Public ContactDr Shalaka P Joshi

Tata Memorial Hosiptal

zealsanghvi93@gmail.com02224176112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026